AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23149137 — intervention group
Group type: COMPARATOR
Intervention: Algorithm A and B (comparison)
Number of subjects: 195
Study 21506190 — intervention group
Group type: EXPERIMENTAL
Intervention: Sage leaf extract (500 mg capsule every 8 hours for 2 months)
Number of subjects: 67
Study 21506190 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 19565667 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal neostigmine 2 microg.kg(‐1) with levobupivacaine
Number of subjects: 60
Study 19565667 — intervention group
Group type: EXPERIMENTAL
Intervention: Caudal neostigmine 4 microg.kg(‐1) with levobupivacaine
Number of subjects: 60
Study 19565667 — intervention group
Group type: COMPARATOR
Intervention: Caudal 0.25% levobupivacaine (1 ml.kg(‐1)) alone
Number of subjects: 60
Study 17037712 — intervention group
Group type: EXPERIMENTAL
Intervention: Fennel extract
Number of subjects: 110
Study 17037712 — intervention group
Group type: COMPARATOR
Intervention: Mefenamic acid
Number of subjects: 110
Study 12622344 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam (2.0 mg/70 kg orally administered)
Number of subjects: 0
Study 12622344 — intervention group
Group type: EXPERIMENTAL
Intervention: Scopolamine (0.6 mg/70 kg subcutaneously administered)
Number of subjects: 0
Study 12622344 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 0
Study 12622344 — intervention group
Group type: EXPERIMENTAL
Intervention: Scopolamine
Number of subjects: 0
Study 12622344 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study 10678601 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric biceps brachii contraction
Number of subjects: 12
Study 10678601 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck flexion
Number of subjects: 12
Study 9070565 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma total homocysteine levels
Number of subjects: 149
Study 8463943 — intervention group
Group type: EXPERIMENTAL
Intervention: DL‐PLGA membrane placed over the roots and alveolar bone
Number of subjects: 17
Study 8463943 — intervention group
Group type: COMPARATOR
Intervention: Control teeth (no DL‐PLGA membrane)
Number of subjects: 17
Study 3751450 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (Trental 400)
Number of subjects: 82
Study 3751450 — intervention group
Group type: COMPARATOR
Intervention: Control group (protocol B, without hemorheologic treatment)
Number of subjects: 82
Study 31683023 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioned Biofeedback
Number of subjects: 73
Study 31683023 — intervention group
Group type: COMPARATOR
Intervention: Biofeedback Only
Number of subjects: 73
Study 31683023 — intervention group
Group type: COMPARATOR
Intervention: Biofeedback+Shock
Number of subjects: 73
Study 29846091 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (MEL) 10 mg
Number of subjects: 10
Study 29846091 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 10
Study 28059034 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 2.5 mg and Haloperidol 2.5 mg (IM) plus Morphine 0.05 mg/kg (IV)
Number of subjects: 87
Study 28059034 — intervention group
Group type: COMPARATOR
Intervention: Distilled water 5 cc (IM) plus Morphine 0.05 mg/kg (IV)
Number of subjects: 87
Study 25495494 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer-determined physical activity measurement
Number of subjects: 149
Study 25495494 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobility limitation (use of a cane or rollator)
Number of subjects: 149
Study 22313740 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill
Number of subjects: 12
Study 22313740 — intervention group
Group type: COMPARATOR
Intervention: Cycle ergometer
Number of subjects: 12
Study 22313740 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill and Cycle ergometer
Number of subjects: 12
Study 20660712 — intervention group
Group type: EXPERIMENTAL
Intervention: Humoral immune response to cryptic epitopes in patients with cancer
Number of subjects: 0
Study 20660712 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of tumor antigens in cancer tissue arrays
Number of subjects: 0
Study 20660712 — intervention group
Group type: EXPERIMENTAL
Intervention: Potential markers for cancer diagnosis, prognosis, or therapy monitoring
Number of subjects: 0
Study 18339487 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensity-modulated radiation therapy (IMRT)
Number of subjects: 20
Study 18339487 — intervention group
Group type: EXPERIMENTAL
Intervention: IMRT with dose escalation
Number of subjects: 20
Study 18339487 — intervention group
Group type: EXPERIMENTAL
Intervention: IMRT with reduced PTV margin (3 mm)
Number of subjects: 20
Study 18339487 — intervention group
Group type: COMPARATOR
Intervention: Six-field conformal radiotherapy
Number of subjects: 20
Study 15359247 — intervention group
Group type: EXPERIMENTAL
Intervention: Acrylic biprism (Tonosafe)
Number of subjects: 40
Study 15359247 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone shield (Tonoshield)
Number of subjects: 40
Study 15359247 — intervention group
Group type: COMPARATOR
Intervention: Standard Goldmann applanation tonometer (GAT)
Number of subjects: 40
Study 12433015 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressive Writing (EW)
Number of subjects: 42
Study 12433015 — intervention group
Group type: COMPARATOR
Intervention: Neutral Writing (NW)
Number of subjects: 42
Study 10488702 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood transfusion and vasoactive drugs followed by sclerotherapy
Number of subjects: 695
Study 10488702 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection sclerotherapy at diagnostic endoscopy
Number of subjects: 695
Study 10488702 — intervention group
Group type: COMPARATOR
Intervention: Bleeding from other sources related to portal hypertension
Number of subjects: 695
Study 10488702 — intervention group
Group type: EXPERIMENTAL
Intervention: Active variceal bleeding at diagnostic endoscopy
Number of subjects: 695
Study 10488702 — intervention group
Group type: EXPERIMENTAL
Intervention: Early bleeding
Number of subjects: 695
Study 10488702 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilirubin
Number of subjects: 695
Study 10488702 — intervention group
Group type: EXPERIMENTAL
Intervention: Encephalopathy
Number of subjects: 695
Study 10488702 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter interval to admission
Number of subjects: 695
Study 10488702 — intervention group
Group type: EXPERIMENTAL
Intervention: Log urea
Number of subjects: 695
Study 9601759 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (1 mg/kg/day i.m. over 3 days)
Number of subjects: 40
Study 9601759 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 40
Study 1827019 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine 5 mg once daily
Number of subjects: 12
Study 1827019 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 6765546 — intervention group
Group type: EXPERIMENTAL
Intervention: Human insulin (recombinant DNA)
Number of subjects: 7
Study 6765546 — intervention group
Group type: COMPARATOR
Intervention: Purified porcine insulin (PPI)
Number of subjects: 7
Study 30589984 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytisine capsules (25-day supply)
Number of subjects: 1266
Study 30589984 — intervention group
Group type: COMPARATOR
Intervention: Varenicline tablets (12-week supply)
Number of subjects: 1266
Study 28095104 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-based exercise (WB; n=15)
Number of subjects: 29
Study 28095104 — intervention group
Group type: EXPERIMENTAL
Intervention: Land-based exercise (LB; n=14)
Number of subjects: 29
Study 25596682 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus plus exemestane
Number of subjects: 106
Study 25596682 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus exemestane
Number of subjects: 106
Study 23906000 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of education (indexed by irregular word reading skill)
Number of subjects: 385
Study 23906000 — intervention group
Group type: EXPERIMENTAL
Intervention: Test version
Number of subjects: 385
Study 23906000 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment site
Number of subjects: 385
Study 23906000 — intervention group
Group type: COMPARATOR
Intervention: Ethnicity
Number of subjects: 385
Study 23906000 — intervention group
Group type: COMPARATOR
Intervention: Years of total education
Number of subjects: 385
Study 21427404 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotrimoxazole (CTX)
Number of subjects: 541
Study 21427404 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 541
Study 18957828 — intervention group
Group type: EXPERIMENTAL
Intervention: Boron neutron capture therapy (BNCT)
Number of subjects: 21
Study 18957828 — intervention group
Group type: EXPERIMENTAL
Intervention: Boron neutron capture therapy (BNCT) followed by X-ray treatment (XRT) of 20 to 30 Gy
Number of subjects: 21
Study 18957828 — intervention group
Group type: EXPERIMENTAL
Intervention: Boron neutron capture therapy (BNCT) (protocol 1 and 2 together)
Number of subjects: 21
Study 18957828 — intervention group
Group type: COMPARATOR
Intervention: Institutional historical controls
Number of subjects: 21
Study 17188853 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval training (3‐min intervals)
Number of subjects: 60
Study 17188853 — intervention group
Group type: COMPARATOR
Intervention: Continuous training
Number of subjects: 60
Study 17188853 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval training and Continuous training
Number of subjects: 60
Study 15149351 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flux hemodialysis
Number of subjects: 1846
Study 15149351 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose hemodialysis
Number of subjects: 1846
Study 15149351 — intervention group
Group type: COMPARATOR
Intervention: Low-flux hemodialysis
Number of subjects: 1846
Study 15149351 — intervention group
Group type: COMPARATOR
Intervention: High-dose hemodialysis
Number of subjects: 1846
Study 12381087 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous ATP injection
Number of subjects: 14
Study 10325874 — intervention group
Group type: EXPERIMENTAL
Intervention: Belladonna C30
Number of subjects: 60
Study 10325874 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 7616871 — intervention group
Group type: EXPERIMENTAL
Intervention: Gynodian Depot cartridges (4 mg estradiovalerate and 200 mg prasteronenantate) given as muscular injection in 6-10 week intervals (mean 7 weeks +/- 4 days)
Number of subjects: 50
Study 2654080 — intervention group
Group type: EXPERIMENTAL
Intervention: naftifin hydrochloride cream
Number of subjects: 19
Study 2654080 — intervention group
Group type: COMPARATOR
Intervention: clotrimazole 1%
Number of subjects: 19
Study 2654080 — intervention group
Group type: COMPARATOR
Intervention: clotrimazole 1% + hydrocortisone 1%
Number of subjects: 19
Study 2654080 — intervention group
Group type: COMPARATOR
Intervention: hydrocortisone 0.5%
Number of subjects: 19
Study 2654080 — intervention group
Group type: COMPARATOR
Intervention: hydrocortisone 1%
Number of subjects: 19
Study 2654080 — intervention group
Group type: COMPARATOR
Intervention: hydrocortisone 2.5%
Number of subjects: 19
Study 1009036 — intervention group
Group type: EXPERIMENTAL
Intervention: Ayre spatula
Number of subjects: 982
Study 1009036 — intervention group
Group type: COMPARATOR
Intervention: Armovical spatula
Number of subjects: 982
Study 31564288 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular Advancement Device (MAD)
Number of subjects: 59
Study 31564288 — intervention group
Group type: COMPARATOR
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 59
Study 26853601 — intervention group
Group type: EXPERIMENTAL
Intervention: Ancient khorasan wheat diet
Number of subjects: 21
Study 26853601 — intervention group
Group type: COMPARATOR
Intervention: Modern control wheat diet
Number of subjects: 21
Study 26486824 — intervention group
Group type: EXPERIMENTAL
Intervention: TAP‐144‐SR (6M) 22.5 mg
Number of subjects: 160
Study 26486824 — intervention group
Group type: COMPARATOR
Intervention: TAP‐144‐SR (3M) 11.25 mg
Number of subjects: 160
Study 24350515 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile bearing high flex knee arthroplasty
Number of subjects: 39
Study 24350515 — intervention group
Group type: COMPARATOR
Intervention: Fixed bearing posterior stabilized knee (LPS)
Number of subjects: 39
Study 21574291 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed combinations of corinetec and gyzaar supplemented by acupuncture reflexotherapy
Number of subjects: 0
Study 21574291 — intervention group
Group type: COMPARATOR
Intervention: Drug therapy without acupuncture
Number of subjects: 0
Study 18824862 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexibuprofen 200 mg
Number of subjects: 102
Study 18824862 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexibuprofen 300 mg
Number of subjects: 102
Study 18824862 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen 400 mg
Number of subjects: 102
Study 16710256 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptifibatide (Integrilin) administered as two boluses of 180 mg/kg followed by infusion of 2 mg/kg per min for 24 hours and 1.3 mg/kg for 48 hours
Number of subjects: 25
Study 16710256 — intervention group
Group type: COMPARATOR
Intervention: Control group (no GP IIb-IIIa antagonists used)
Number of subjects: 25
Study 16710256 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptifibatide
Number of subjects: 25
Study 15633811 — intervention group
Group type: EXPERIMENTAL
Intervention: Real intradermal acupuncture on shen‐men (He‐7) and nei‐kuan (EH‐6) for 2 days
Number of subjects: 30
Study 15633811 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture on the same points for 2 days
Number of subjects: 30
Study 11319675 — intervention group
Group type: EXPERIMENTAL
Intervention: BIM (Breathe with Interactive Music)
Number of subjects: 33
Study 11319675 — intervention group
Group type: COMPARATOR
Intervention: Walkman (control)
Number of subjects: 33
Study 9431347 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive medical therapy and monitoring by experienced physicians and surgeons for patients with fulminant colitis, toxic megacolon, or perforation.
Number of subjects: 0
Study 7943771 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous + leukocyte‐depleted red blood cell transfusion (800 +/- 200 mL autologous blood and 2.2 +/- 2.0 units of SAGM red blood cells)
Number of subjects: 24
Study 7943771 — intervention group
Group type: COMPARATOR
Intervention: Standard allogeneic red blood cell transfusion (5.5 +/- 1.4 units of SAGM red blood cells)
Number of subjects: 24
Study 3062352 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 120
Study 3062352 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 120
Study 3062352 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam
Number of subjects: 120
Study 3062352 — intervention group
Group type: COMPARATOR
Intervention: All groups (Diazepam, Flunitrazepam, Midazolam)
Number of subjects: 120
Study 31826232 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 PUFAs
Number of subjects: 44
Study 31826232 — intervention group
Group type: COMPARATOR
Intervention: saline
Number of subjects: 44
Study 31504126 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 years of tamoxifen treatment
Number of subjects: 583
Study 31504126 — intervention group
Group type: COMPARATOR
Intervention: 5 years of tamoxifen treatment
Number of subjects: 583
Study 28682965 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporary defunctioning stoma
Number of subjects: 98
Study 28682965 — intervention group
Group type: COMPARATOR
Intervention: No temporary defunctioning stoma
Number of subjects: 98
Study 25945500 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin monotherapy
Number of subjects: 104
Study 25945500 — intervention group
Group type: COMPARATOR
Intervention: Insulin monotherapy
Number of subjects: 104
Study 23716471 — intervention group
Group type: EXPERIMENTAL
Intervention: Toxoplasma gondii infection
Number of subjects: 410
Study 23716471 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytomegalovirus infection
Number of subjects: 410
Study 22137077 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial conservative management without cardiac catheterization
Number of subjects: 499
Study 22137077 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial medical therapy after publication of trial results
Number of subjects: 499
Study 19245713 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear mixed-effects models for continuous outcomes
Number of subjects: 0
Study 19245713 — intervention group
Group type: EXPERIMENTAL
Intervention: Ordinary logistic regression for binary outcomes
Number of subjects: 0
Study 19245713 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalized linear mixed models
Number of subjects: 0
Study 15992835 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenia patients
Number of subjects: 51
Study 15992835 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyslexia subjects
Number of subjects: 51
Study 15992835 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 51
Study 15992835 — intervention group
Group type: EXPERIMENTAL
Intervention: Total MPA and FA measures
Number of subjects: 51
Study 15992835 — intervention group
Group type: EXPERIMENTAL
Intervention: High palate (individual MPA item)
Number of subjects: 51
Study 14700145 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamins and folic acid supplementation
Number of subjects: 29
Study 14700145 — intervention group
Group type: COMPARATOR
Intervention: Multivitamins only (Control)
Number of subjects: 29
Study 11967798 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 17
Study 11967798 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 17
Study 8976781 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% betamethasone cream applied twice daily for 4 weeks
Number of subjects: 40
Study 8976781 — intervention group
Group type: COMPARATOR
Intervention: Neutral cream (Vaseline) applied twice daily for 4 weeks
Number of subjects: 40
Study 1353011 — intervention group
Group type: EXPERIMENTAL
Intervention: L-threonine (Thr)
Number of subjects: 30
Study 1353011 — intervention group
Group type: COMPARATOR
Intervention: Control (Vitamin B or Carnitine)
Number of subjects: 30
Study 6396839 — intervention group
Group type: EXPERIMENTAL
Intervention: Cloxacillin (2 g intravenously 2 hours before operation, followed by 1 g every 6 hours for 2 days and 1 g orally for 8 more days postoperatively)
Number of subjects: 100
Study 6396839 — intervention group
Group type: COMPARATOR
Intervention: Control group (no antibiotics)
Number of subjects: 100
Study 6396839 — intervention group
Group type: EXPERIMENTAL
Intervention: Cloxacillin
Number of subjects: 100
Study 6396839 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 30447035 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic disease status
Number of subjects: 237
Study 30447035 — intervention group
Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 237
Study 30447035 — intervention group
Group type: EXPERIMENTAL
Intervention: Health service utilisation
Number of subjects: 237
Study 30052055 — intervention group
Group type: EXPERIMENTAL
Intervention: MG-NMES
Number of subjects: 20
Study 30052055 — intervention group
Group type: COMPARATOR
Intervention: C-NMES
Number of subjects: 20
Study 27654602 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced intervention (wearable device and web interface)
Number of subjects: 471
Study 27654602 — intervention group
Group type: COMPARATOR
Intervention: Standard intervention (standard behavioral weight loss intervention)
Number of subjects: 471
Study 27654602 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (enhanced and standard interventions)
Number of subjects: 471
Study 24906822 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated diastolic hypertension (DBP24≥80 mm Hg)
Number of subjects: 8341
Study 24906822 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated systolic hypertension (SBP24≥130 mm Hg)
Number of subjects: 8341
Study 24906822 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed diastolic plus systolic hypertension
Number of subjects: 8341
Study 24906822 — intervention group
Group type: EXPERIMENTAL
Intervention: DBP24 below age 50
Number of subjects: 8341
Study 24906822 — intervention group
Group type: EXPERIMENTAL
Intervention: SBP24 above age 50
Number of subjects: 8341
Study 22513516 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% HES 130/0.4
Number of subjects: 76
Study 22513516 — intervention group
Group type: COMPARATOR
Intervention: 10% HES 200/0.5
Number of subjects: 76
Study 19852877 — intervention group
Group type: EXPERIMENTAL
Intervention: Thought suppression demonstration
Number of subjects: 91
Study 17845270 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen (20-140 mg/day)
Number of subjects: 16
Study 17845270 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 11694609 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation (10 mg/d)
Number of subjects: 478
Study 11694609 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (10 mg/d)
Number of subjects: 478
Study 11694609 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron + Zinc supplementation (10 mg of each/d)
Number of subjects: 478
Study 11694609 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 478
Study 9212763 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (200 mg intravenously)
Number of subjects: 300
Study 9212763 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 8134718 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled budesonide 1.6 mg daily
Number of subjects: 40
Study 8134718 — intervention group
Group type: COMPARATOR
Intervention: Oral prednisone 10 mg daily
Number of subjects: 40
Study 3306546 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% levobunolol
Number of subjects: 0
Study 3306546 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% levobunolol
Number of subjects: 0
Study 3306546 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily instillation for 1 week
Number of subjects: 0
Study 29754267 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory-based tri-focal intervention
Number of subjects: 432
Study 29754267 — intervention group
Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 432